InspireMD, Inc. Appoints Patrick Jamnik as Vice President of Business Development and Strategic Initiatives and Reports

InspireMD, Inc. Appoints Patrick Jamnik as Vice President of Business
Development and Strategic Initiatives and Reports Inducement Grants Under NYSE
American Company Guide §711(a)

TEL AVIV, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE
American: NSPR) (“Company”), the developer of the CGuard™ Embolic Prevention
System (EPS) for the prevention of stroke caused by carotid artery disease
(CAD), today announced the appointment of Patrick Jamnik as vice president,
business development and strategic initiatives. In this newly created
position, Mr. Jamnik will oversee the Company’s business development
activities and play a key role in advancing its short and long-term strategic
goals, with much of his focus being the U.S. market.

“At different times throughout my career, I have been fortunate to see the
powerful impact created when pioneering technology encounters genuine unmet
clinical needs. CGuard™ EPS presents the opportunity to create such an impact
on the advancement of carotid artery 
Read More